The DENGVAC study: Preliminary findings on the immunogenicity of the TAK-003 dengue vaccine
Preliminary data showed that TAK-003 vaccine is safe and immunogenic. The first vaccine dose elicits a functional antibody and a robust T-cell response. Further analyses on the current cohort are ongoing.
Authors
- Stefania Notari
- Patrizia De Marco (ORCID: https://orcid.org/0000-0001-8498-3750)
- Laura Ponzetta
- Marta Tiberi (ORCID: https://orcid.org/0000-0002-5287-424X)
- Delia Goletti
- Emanuele Nicastri
- Linda Petrone
- Eleonora Lalle
- Alba Grifoni
- Alessandro Sette
- Serena Vita
- Fabrizio Maggi
- Laura Scorzolini
- Silvia Cammisa
- Francesca Colavita
- Luigi Rosa
- Eleonora Tartaglia
- Alessandra D’Abramo
- Eleonora Cimini
Institutions
- La Jolla Institute for Immunology (US)
- Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Sapienza University of Rome (IT)
Publication Details
- Journal
- Journal of Infection
- Published
- 2026-02-19
- DOI
- https://doi.org/10.1016/j.jinf.2026.106707
- Primary Topic
- Mosquito-borne diseases and control
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Ministero della Salute